Genetically engineered probiotics (Q35542652)

8 August 2017

1 reference

title

Genetically engineered probiotics (English)

1 reference

8 August 2017

0 references

Lothar Steidler

1

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14507594

13 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1521691803000726?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1521-6918(03)00072-6

https://api.elsevier.com/content/article/PII:S1521691803000726?httpAccept=text/plain

13 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1521-6918(03)00072-6

Best Practice and Research: Clinical Gastroenterology

13 March 2024

published in

1 reference

8 August 2017

volume

17

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

861-876

1 reference

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Saccharomyces boulardii in maintenance treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Probiotics: a novel approach in the management of food allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Cariogenic potential in vitro in man and in vivo in the rat of lactate dehydrogenase mutants of Streptococcus mutans

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

L-(+)-lactate dehydrogenase deficiency is lethal in Streptococcus mutans

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Genetic and physiological analysis of the lethal effect of L-(+)-lactate dehydrogenase deficiency in Streptococcus mutans: complementation by alcohol dehydrogenase from Zymomonas mobilis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Colonization of the human oral cavity by a strain of Streptococcus mutans.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Colonization of the human oral cavity by a Streptococcus mutans mutant producing increased bacteriocin

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

In situ delivery of passive immunity by lactobacilli producing single-chain antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Immunopathogenesis of recurrent vulvovaginal candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Vaginal Immunization with Recombinant Gram‐Positive Bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Production and characterization of yeast killer toxin monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Chronic consumption of fresh but not heated yogurt improves breath-hydrogen status and short-chain fatty acid profiles: a controlled study in healthy men with or without lactose maldigestion

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Survival, physiology, and lysis of Lactococcus lactis in the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

The 'biodrug' concept: an innovative approach to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Engineered yeasts simulating P450-dependent metabolisms: tricks, myths and reality.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Lactobacilli as live vaccine delivery vectors: progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Role of IL-10 for induction of anemia during inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Construction of an efficient biologically contained pseudomonas putida strain and its survival in outdoor assays

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Dual system to reinforce biological containment of recombinant bacteria designed for rhizoremediation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Streptavidin-based containment systems for genetically engineered microorganisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

An expression vector system providing plasmid stability and conditional suicide of plasmid-containing cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Evaluation of the E. coli ribosomal rrnB P1 promoter and phage-derived lysis genes for the use in a biological containment system: a concept study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

A gene containment strategy based on a restriction-modification system

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Universal barrier to lateral spread of specific genes among microorganisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

The alanine racemase gene is essential for growth of Lactobacillus plantarum

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Use of the alr gene as a food-grade selection marker in lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Development of a chromosome-plasmid balanced lethal system for Lactobacillus acidophilus with thyA gene as selective marker

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Construction of a food-grade host/vector system for Lactococcus lactis based on the lactose operon

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

A food-grade cloning system for industrial strains of Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

A food-grade cloning vector for lactic acid bacteria based on the nisin immunity gene nisI.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Construction of a food-grade multiple-copy integration system for Lactococcus lactis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Cloning, expression, and chromosomal stabilization of the Propionibacterium shermanii proline iminopeptidase gene (pip) for food-grade application in Lactococcus lactis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6918%2803%2900072-6

7 January 2021

Changing paradigms in caries management

series ordinal

11

1 reference

https://api.crossref.org/works/10.1016/S1521-6918(03)00072-6

Oral passive immunization against dental caries in rats by use of hen egg yolk antibodies specific for cell-associated glucosyltransferase of Streptococcus mutans

13 March 2024

series ordinal

20

1 reference

https://api.crossref.org/works/10.1016/S1521-6918(03)00072-6

Escherichia coli K12 relA strains as safe hosts for expression of recombinant DNA

13 March 2024

series ordinal

53

1 reference

https://api.crossref.org/works/10.1016/S1521-6918(03)00072-6

13 March 2024

Identifiers

1 reference

8 August 2017

1 reference